The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements
eLife · 03.02.2026 · 14
DOI: 10.7554/elife.109280 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 03.02.2026. Verfasst von Andria Koulle und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Transcription Factors, Enhancer Elements, Genetic, Chromatin Assembly and Disassembly, Mi-2 Nucleosome Remodeling and Deacetylase Complex. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Isaac Newton Trust, Wellcome.
Abstract (Originalsprache)
Chromatin organisation and transcriptional regulation are tightly coordinated processes that are essential for maintaining cellular identity and function. ATP-dependent chromatin remodelling proteins play critical roles in control of genome structure and in regulating transcription across eukaryotes. Their essential nature, however, has made it difficult to define exactly how these functions are mediated. The chromatin remodeller CHD4 has been shown to be capable of sliding nucleosomes in vitro, and to regulate chromatin accessibility and gene expression in vivo. Using an inducible depletion system, here we identify a second mechanism of action for CHD4 in actively restricting the residence time of transcription factors (TFs) on chromatin. Together, these activities result in distinct, context-dependent outcomes: at highly accessible regulatory elements, CHD4 limits TF binding to maintain regulatory function, while at low-accessibility euchromatic regions, it prevents TF engagement and sustains chromatin compaction, thereby silencing cryptic enhancers. Collectively, these mechanisms enable CHD4 to reduce transcriptional noise while preserving the responsiveness of active regulatory networks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
- Living Systems Institute, University of Exeter, Exeter, United Kingdom.
ORCID-Profile: Andria Koulle, Oluwaseun Ogundele, Devina Shah, India Baker, Maya Lopez, David Lando, Nicola Reynolds, Ramy Ragheb, Ernest D Laue, Brian Hendrich
Förderung
- Medical Research Council
- Isaac Newton Trust
- Wellcome
- Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge
- Wellcome Trust
- Wolfson College, University of Cambridge
- AstraZeneca
Zitieren
APA
Koulle, A., Ogundele, O., Shah, D., Baker, I., Lopez, M., Lando, D., Reynolds, N., Ragheb, R., Laue, E. D., & Hendrich, B. (2026). The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements. eLife, 14. https://doi.org/10.7554/elife.109280
Vancouver
Koulle A, Ogundele O, Shah D, Baker I, Lopez M, Lando D, et al. The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements. eLife. 2026;14. doi:10.7554/elife.109280
BibTeX
@article{Koulle2026,
author = {Koulle, Andria and Ogundele, Oluwaseun and Shah, Devina and Baker, India and Lopez, Maya and Lando, David and Reynolds, Nicola and Ragheb, Ramy and Laue, Ernest D and Hendrich, Brian},
title = {The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements},
journal = {eLife},
year = {2026},
volume = {14},
doi = {10.7554/elife.109280}
}
EUVIMED